IBSRELA Tablet Ref.[10240] Active ingredients:

Source: FDA, National Drug Code (US)  Revision Year: 2020 

1. Indications and Usage

IBSRELA is indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults.

2. Dosage and Administration

The recommended dosage of IBSRELA in adults is 50 mg orally twice daily.

Administration Instructions:

  • Take IBSRELA immediately prior to breakfast or the first meal of the day and immediately prior to dinner [see Clinical Pharmacology (12.2)].
  • If a dose is missed, skip the missed dose and take the next dose at the regular time. Do not take 2 doses at the same time.

10. Overdosage

Based on nonclinical data, overdose of IBSRELA may result in gastrointestinal adverse effects such as diarrhea as a result of exaggerated pharmacology with a risk for dehydration if diarrhea is severe or prolonged [see Warnings and Precautions (5.1)].

16.2. Storage and Handling

Store at room temperature, between 68°F and 77°F (20°C and 25°C).

Keep in original container and protect from moisture. Keep the container of IBSRELA tightly closed and in a dry place.

Do not remove desiccant from the bottle. Do not subdivide or repackage.

< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈